IN 1919, Pardee attempted to assess the daily maintenance requirements of digitalis.1 He administered digitalis to patients in small repetitive doses until toxicity occurred. Digitalis was then withheld for some days and the patients were again given digitalis until toxicity developed. He calculated that the amount required to achieve toxicity the second time minus that required the first time divided by the number of days was equal to the daily elimination of digitalis. Thus, a fixed daily rate of excretion was assumed in these calculations. However, in 1923, Gold2 demonstrated that animals did not eliminate a fixed quantity of digitalis in a unit of time, but rather excreted a fraction of the amount present. He then proceeded to confirm the lack of a fixed rate of excretion in man. In 1929, Gold and DeGraff3 stated "that digitalis cumulation tends to be a self-limiting process; that a given dose of digitalis may show evidence of cumulation at first and later cease to show cumulation when the same daily dose is continued.... In other words, as the quantity of digitalis in the body increases, the amount eliminated daily also increases until the quantity eliminated equals the daily dose; then further cumulation no the daily dose.... The degree of depression of conduction, as shown by the changes in the heart rate in patients with auricular fibrillation, was employed as evidence of the intensity of digitalis action."
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In the present experiments, tritiated digoxin was utilized to provide direct verification of digitalis cumulation on repetitive doses. These studies further demonstrate that the administration of an initial larger dose of digoxin followed by daily maintenance doses results in the same ultimate accumulation of drug as that which would follow a loading dose.
Methods
Eight healthy male inmates of the District of Columbia Jail volunteered for this study. Their ages ranged from 28 to 44 years. None had a history of cardiac, hepatic, or renal disease. Physical examinations were all within normal limits. Laboratory tests, which included chest roentgenograms, electrocardiograms, routine hemograms, urinalyses, blood urea nitrogen, and fasting blood sugar determinations were all normal.
There were five subjects in the no-loadingdose group. They were given 0.5 mg of tritiated digoxin by mouth at 9:00 AM each day for 9 to 14 days. The digoxin had a specific activity of either 56.2 or 108.1 ,uc per milligram. The glycoside, which was present in 95% ethyl alcohol, was diluted in a cup to approximately 20 ml with water prior to ingestion. The cup was washed three times with equal amounts of water. Blood samples, collected with 20 mg of disodium ethylene diamine tetra-acetic acid as an anticoagulant, were drawn at 3, 9, and 30 minutes, and at 1, 2, 8, and 24 hours after the dose was given on the fourth, eighth, and twelfth days. On each of the other days, blood samples were collected once daily just before the drug was given. All urine was collected at 12-hour intervals starting at 9:00 AM daily. Total 24-hour stool collections were obtained daily. Blood samples and excreta were obtained for 8 days after the last dose of tritiated digoxin was administered.
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The loading-dose group also consisted of five subjects. Volunteers R.T. and A.J. had been subjects in the previous group. An interval of at least 2 months had elapsed before these two individuals were restudied. The specific activity of the tritiated digoxin was either 54.4 or 108.1 ,uc per milligram. On the first day of the study, the subjects were given 1.0 mg of the tritiated cardiac glycoside orally at 9:00 AM followed by 0.5 mg in 6 and 12 hours. They received 0.5 mg of tritiated digoxin daily thereafter. Blood samples were drawn prior to each dose on the first day. Thereafter, the schedule followed was identical with that described for the no-loading-dose group with the exception of urine collections, which were for 6-hour periods for the first 12 hours, and for 12-hour periods thereafter.
In order to test the effect of an increase in urinary flow on the excretion of tritiated digoxin, 160 mg of the diuretic, furosemide, was given in divided doses to three subjects in the loadingdose group, and two subjects in the no-loadingdose group on the second to fifth days after digoxin administration had been stopped.
The radioactivity in each urine sample was determined in triplicate by pipetting a 0.2-ml aliquot of urine into vials containing the naphthalene-dioxane counting solution described by Bray.4 Stools were homogenized in a blender and aliquots of known weight were dried and combusted by a modification of the Schoniger combustion technique. 5 Evidence that the biotransformation of digoxin in urine and stool was not related to degradation after passage was obtained by adding tritiated digoxin to the excreta which did not contain radioactivity. The samples were allowed to incubate at room temperature for 72 hours, were then lyophilized, and the 20% chloroform in ethanol extract was chromatographed. Only one peak of activity corresponding to digoxin was obtained.
Results
The radioactivity in sequential samples of blood following daily oral administration of an alcoholic solution of tritiated digoxin indicates that intestinal absorption begins within 30 minutes. A peak concentration of activity in blood is reached in 1 hour. Since the pattern of absorption was similar on the fourth, eighth, and twelfth days of the experiment, the data for those days were combined ( fig. 1 ).
The concentration of digoxin* in the blood during the first 9 days of administration is shown in figure 2 . In the no-loading-dose group, the concentration of radioactivity in blood increased daily until the sixth day; thereafter, it appeared to reach a plateau at a concentration of the equivalent of 1 ,ug of digoxin per liter. In the loading-dose group, the activity in the blood rose rapidly during the *Hereafter, when digoxin is used in reference to concentration in blood or excretion in urine or stool, it refers to radioactivity in the form of digoxin and metabolites. Figure 3 Concentration of radioactivity in blood in three subjects of the loading-dose group wh1o received tritiated digoxin for 14 days.
remained constant in three subjects of the loading-dose group given the drug for 14 days ( fig. 3) .
In order to determine whether the concentration of radioactivity in blood was a direct index of tissue concentration, samples of tissue from various organs would have had to be obtained. Since this was not possible, the amount of drug retained was calculated on a daily and cumulative basis by subtracting the activity excreted each day from the activity administered daily. The results are shown in figure 4. Concentration of radioactivity in blood in the two groups of subjects during the first 9 days of the study.
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Daily balance of tritiated digoxin over a 2-week period in the two groups of patients studied. The daily intake of digoxin is indicated by the height of the bar above the zero base line. Downward from the intake is plotted urinary excretion of digoxin (cross-hatched area) and stool excretion of digoxin (solid area 
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The no-loading-dose group was in net positive balance of radioactivity for at least 2 days and possibly for the first 4 days. Thereafter, an equilibrium occurred between the amount of digoxin given and excreted. The apparent slight daily retention of digoxin may be real or represent loss of radioactivity in collection or analysis.
The loading-dose group had retention of radioactivity equivalent to 1.407 mg on the first day. Thereafter, when 0.5 mg of digoxin was given daily, a net loss of digoxin occurred during 3 of the 6 days that followed. Table 1 shows the calculated cumulative retention of digoxin of the two groups during the first week. Although the data suggest that the loading-dose group retained more drug, there was no statistical difference betveen the two groups (P > 0.1). At least three subjects in each group had calculated retention of the equivalent of 1.04 to 1.22 mg of digoxin. Full details regarding the administration and excretion of digoxin in the two groups are presented in table 2.
The excretion of greater activity by the loading-dose group than by the no-loadingdose group is consistent with the thesis that the quantity of digoxin excreted each day is a function of the amount present in the body. a lower excretion fraction may be due to small unexplained daily losses of radioactivity, which collectively increase the amount of digoxin calculated as retained. Therefore, the calculated fraction excreted is shown as a gradual decrease.
Further evidence that the amount of digoxin excreted is a function of that present in the body is shown in figure 6 , in which there was an exponential fall in daily activity excreted after administration of digoxin was stopped.
The administration of furosemide 2 to 5 days after administration of the drug was discontinued resulted in a mean excretion of urine two and a half times more than that of the preceding day. Despite this increase, the urinary excretion of tritiated digoxin was unaffected.
Diuresis, however, can result in an increase in the excretion of tritiated digoxin in a patient with oliguria due to hepatic decom- pensation. 9 The effect of diuresis on the excretion of digoxin in patients with congestive heart failure has not been reported.
Extraction and partition chromatography of urine and stool of two subjects at intervals during the experiment indicated that between 87.03 and 92.43% of the activity recovered in the urine was eluted from the alumina column by 20% ethanol in chloroform (table 3) . The same eluate obtained from stool contained from 74.3 to 87.8% of activity recovered in the feces. These data are consistent with those previously obtained following the administration of a single intravenous dose to normal subjects.6 Chromatography of the 20% ethanol in chloroform fraction of urine showed that a mean of 68.3% of activity present in the chromatogram migrated with digoxin with peaks of 3.5% of activity migrating with digoxigeninmono-digitoxoside, and 10.87% migrating with digoxigenin-bis-digitoxoside ( fig. 7) . However, evidence of a greater degree of biodegradation was present in the 20% ethanol in chloroform extract of stool obtained from several of the subjects. In these chromatograms of stool, a mean of 44.2% of activity in the chromatogram was present in the digoxin peak, 19.4% migrated with digoxigenin-mono-digitoxoside and 19.7% migrated with digoxigenin-bis-digitoxoside ( fig. 8 ). The greater amount of degradation of digoxin in stool may account for the 8.6 to 20.1% of activity recovered in the water-soluble fraction since biotransformation of digoxin (digoxigenin-tri-digitoxoside) to the bis and mono forms results in the splitting of one and two digitoxose molecules respectively. The digitoxose sugars are water soluble and have been found in this fraction.7
Discussion
When digoxin is given as an alcoholic solution, rapid absorption occurs since activity appears in the blood within 30 minutes after drug ingestion ( fig. 1) . It is thus apparent that at least some of the tritiated digoxin was Our data confirm information previously obtained after a single dose of digoxin given intravenously or orally, that the major route of excretion of digoxin in man is by the renal route.6 9, 11 However, stool excretion of digoxin was not insignificant since 32.3% of activity was detected in the stool in the no-loadingdose group and 26.3% in the loading-dose group (table 2) . The urine-to-stool ratio was 2.1:1 and 2.4:1 in these two groups, respectively. The present data do not permit an estimate of the per cent of drug absorbed since fecal excretion of radioactivity may be due to biliary or intestinal excretion of drug and metabolites after partial or complete absorption.
Since tritiated digoxin appears to be excreted largely in unchanged form, it is probable that it is also present in tissue in the same state. Support for this thesis has been obtained from chromatographic analysis of cardiac and kidney tissue from dogs given tritiated digoxin. 8 In the present investigation, the subjects given 0.5 mg of tritiated digoxin daily without a loading dose showed a continuous rise of radioactivity in blood until the sixth day, when the concentration of radioactivity reached the equivalent of 1.0 ,ug per liter of digoxin ( fig. 2) . This rise, which indicated that an accumulation of tritiated digoxin had occurred, was confirmed by the calculated retention of digoxin (table 1). In the group given an initial dose of 2 mg of tritiated digoxin on the first day, however, the concentration of radioactivity in blood was the same as that in the no-loading-dose group by the sixth day ( fig. 2) . If blood concentration is a reflection of tissue concentration, then it may be said that the tissue concentrations of tritiated digoxin and metabolites were similar in the two groups by the sixth day. The The excretion data for the subjects given the loading dose also appear to be consistent with a daily excretion of 30% of the body dose. Theoretically, 0.6 mg should be excreted on the first day after the dose of 2.0 mg was given, yielding a retention of 1.4 mg. After the next 0.5 mg is given, a body load of 1.9 mg is available for excretion. If 30% or 0.57 mg of this is eliminated, 1.33 mg should be left. Again, by repetitive calculation, the loading dose is gradually excreted until 1.2 mg is retained (table 5) . The data in table 1 and figure 4 are in general accord with these theoretical calculations.
The evidence indicates that the loading dose of digoxin is excreted and that the amount retained after 1 week theoretically is no greater than 0.13 mg more than that present in the no-loading-dose group. It follows, therefore, that the use of the initial digitalizing dose should be restricted to patients in whom the maximum effect of the drug is needed immediately. If it appears clinically that the full effect is not needed at once, then digitalization may be effected more gradually by the no-loading-dose method.
If digitalization is initiated with a loading dose followed by a maintenance dose of 0.5 mg, it appears unnecessary to use a loading dose of digoxin greater than about 1.2 mg for the average adult. It is recognized that, when cardiac glycosides are used to achieve an The metabolism of digoxin was investigated in eight normal subjects during daily administration of 0.5 mg of the drug for 1 to 2 Circulation, Volume XXXIV, November 1966 weeks. Two dose schedules were used. One group was given 2.0 mg of tritiated digoxin whereas this loading dose was omitted in the other group. Serial blood samples and collection of total urine and stool were analyzed for radioactivity. The fraction of urine and stool which had the greatest amount of activity was further examined by paper chromatography.
Absorption of an alcoholic solution of tritiated digoxin began within 30 minutes. A peak concentration of activity in blood was reached in 1 hour. Cumulation of digoxin was shown to occur even though the initial loading dose was not given. By the sixth day, there was no statistical difference in the concentration of radioactivity in the blood between the two groups. The data are consistent with a daily excretion of digoxin in urine and stool of about 30% of that amount present in the body. With subjects receiving 0.5 mg daily for more than 1 week, the total daily body accumulation was in the range of 1.2 mg.
Digoxin administered to man persists in the tissues in unchanged form. Among the metabolites of digoxin were those which differed from the parent compound by the loss of one or two of the three sugar molecules. Digoxin was excreted predominantly by the kidney. The ratio of radioactivity excreted in the urine as compared with the fecal excretion was about 2:1.
The implication of the present study for clinical practice is that the initial loading dose is not necessary except when the maximum effect of the drug is needed within 1 to 873 2 days. If the full effect is not required within this time, the same effect may be obtained within a week by administering digoxin without the necessity of a loading dose.
